Author
P. K. Newton
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2017-2022 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 17 mutual co-author links7 papers
Recent·Most cited
Optimal dynamic incentive scheduling for Hawk-Dove evolutionary games
K. Stuckey, R. Dua, Y. Ma, J. Parker, P. K. Newton
This paper develops optimal dynamic incentive schedules for Hawk-Dove evolutionary games to maximize or minimize aggressive population frequency over time.
bioRxiv · Aug 15, 2021Evolutionary Biology
Are adaptive chemotherapy schedules robust? A three-strategy stochastic evolutionary game theory model
This paper evaluates the robustness of adaptive chemotherapy schedules using a stochastic evolutionary game theory model and finds that error distributions grow exponentially with treatment cycles, leading to treatment failure.
bioRxiv · Feb 28, 2021Biophysics
Maximizing cooperation in the prisoner's dilemma evolutionary game via optimal control
This paper develops an optimal control theory to maximize cooperation in the prisoner's dilemma game by dynamically adjusting payoffs over time, with applications in evolutionary biology and related fields.
bioRxiv · Jul 13, 2020Evolutionary Biology
Towards multi-drug adaptive therapy
J. West, L. You, J. Zhang, R. A. Gatenby, J. Brown, P. K. Newton, A. R. Anderson
This paper introduces three novel concepts to aid in designing multi-drug adaptive therapies for cancer by analyzing tumor evolution dynamics and treatment strategies.
bioRxiv · Jul 25, 2019Cancer Biology
Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment
The paper introduces an evolutionary model to explain competitive release in metastatic castration-resistant prostate cancer, showing how treatment reduces sensitive cells and allows resistant cells to dominate.
bioRxiv · Feb 7, 2018Cancer Biology
Chemotherapeutic dose scheduling based on tumor growth rates: the case for low dose metronomic high entropy therapies
This paper compares low dose metronomic and maximum tolerated dose chemotherapy strategies, finding that metronomic approaches can reduce tumor cells more effectively, especially for fast-growing tumors over multiple cycles.
bioRxiv · Jul 19, 2017Cancer Biology